Outcomes in uncomplicated β-hemolytic Streptococcal bloodstream infections transitioned from IV to oral antimicrobial therapy
For β-hemolytic <i>Streptococcus</i> uBSI, OAT was associated with decreased length of stay without adverse clinical outcomes. Opportunities exist to modify clinical management of uBSI.
Authors
- Elizabeth Lyden (ORCID: https://orcid.org/0000-0002-1635-6365)
- Jasmine R Marcelin (ORCID: https://orcid.org/0000-0003-0504-753X)
- Cristina Torres
- Trevor Van Schooneveld (ORCID: https://orcid.org/0000-0002-9928-4546)
- Bryan Alexander (ORCID: https://orcid.org/0000-0001-7656-2569)
- Jihyun Ma (ORCID: https://orcid.org/0000-0002-4761-9607)
- Mackenzie Keintz (ORCID: https://orcid.org/0000-0002-7222-8245)
- Molly M. Miller
Institutions
- Nebraska Medical Center (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10109
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00